Zobrazeno 1 - 10
of 31
pro vyhledávání: '"A. G. Blidner"'
Autor:
Bernardo L. Rapoport, Vickie R. Shannon, Tim Cooksley, Douglas B. Johnson, Lindsay Anderson, Ada G. Blidner, Gregory R. Tintinger, Ronald Anderson
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
The development of immune checkpoint inhibitors (ICIs) has revolutionized cancer treatment, with agents such as nivolumab, pembrolizumab, and cemiplimab targeting programmed cell death protein-1 (PD-1) and durvalumab, avelumab, and atezolizumab targe
Externí odkaz:
https://doaj.org/article/407b43c0a26f43a19b522c1f1855c2df
Autor:
Nadia Bannoud, Tomás Dalotto-Moreno, Lucía Kindgard, Pablo A. García, Ada G. Blidner, Karina V. Mariño, Gabriel A. Rabinovich, Diego O. Croci
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Hypoxia, angiogenesis, and immunosuppression have been proposed to be interrelated events that fuel tumor progression and impair the clinical effectiveness of anti-tumor therapies. Here we present new mechanistic data highlighting the role of hypoxia
Externí odkaz:
https://doaj.org/article/12607910d9c745599f3311cd5430e0e4
Autor:
Yamila I. Rodriguez, Ludmila E. Campos, Melina G. Castro, Nadia Bannoud, Ada G. Blidner, Verónica P. Filippa, Diego O. Croci, Gabriel A. Rabinovich, Sergio E. Alvarez
Publikováno v:
Cells, Vol 9, Iss 11, p 2469 (2020)
The role of tumor necrosis factor-α (TNF-α) in shaping the tumor microenvironment is ambiguous. Consistent with its uncertain role in melanoma, TNF-α plays a dual role, either acting as a cytotoxic cytokine or favoring a tumorigenic inflammatory m
Externí odkaz:
https://doaj.org/article/0624a3162ac64691a87d4bdecedb176a
Autor:
Ilya G. Glezerman, Jennifer N. Choi, Pamela K. Ginex, Dipti Gupta, Bernardo Leon Rapoport, Tim Cooksley, Douglas B. Johnson, Monica Girotra, Michael Dougan, Vickie R. Shannon, Ronald Anderson, Ada G. Blidner, Maria E. Suarez-Almazor
Publikováno v:
Supportive Care in Cancer. 28:6111-6117
Despite the success and ongoing promise of monoclonal antibody-targeted immune checkpoint inhibitor immunotherapy of advanced malignancies, in particular, antibodies directed against CTLA-4 and PD-1/PD-L1, the development of immune-related adverse ev
Autor:
Michael Dougan, Jennifer N. Choi, Ronald Anderson, Maria E. Suarez-Almazor, Douglas B. Johnson, Tim Cooksley, Ada G. Blidner, Vickie R. Shannon, Ilya G. Glezerman, Bernardo Leon Rapoport, Monica Girotra, Pamela K. Ginex, Dipti Gupta
Publikováno v:
Support Care Cancer
Immune-related adverse events (IrAEs) affecting the gastrointestinal (GI) tract and liver are among the most frequent and most severe inflammatory toxicities from contemporary immunotherapy. Inflammation of the colon and or small intestines (entero)c
Autor:
Nadia Bannoud, P. Alfredo García, Julian Gambarte-Tudela, Victoria Sundblad, Alejandro J. Cagnoni, Camila A. Bach, Juan M. Pérez Saez, Ada G. Blidner, Sebastián M. Maller, Karina V. Mariño, Mariana Salatino, Juan P. Cerliani, Gabriel A. Rabinovich, Diego O. Croci
Publikováno v:
Methods in Molecular Biology ISBN: 9781071620540
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9041ce550902794565f91bc19d0894aa
https://doi.org/10.1007/978-1-0716-2055-7_34
https://doi.org/10.1007/978-1-0716-2055-7_34
Autor:
Suchitra D. Gopinath, John Protzko, Samuel Nathan Kirshner, Ada G. Blidner, Elvira Sojli, Matúš Soták, Daniel A. Friedman, Bhavya Perma, Andreas Kupz, Roland Ruscher, Michael Tran Duong, Morgan Daly Dedyo, Michael A. Tarselli, Juliet Tegan Johnston, Mark Martin Jensen, Michael J. Strong, Anant Kumar Srivastava, Nikos Konstantinides, Felicia Beardsley, Athanasia Nikolaou, Katie Burnette, Isaac Z. Tanner, Divyansh Agarwal, JiaJia Fu, Basant A. Ali, Julia Yuen, Benedito Alves de Oliveira
Publikováno v:
Science. 371:22-24
With 2020 finally behind us, we can begin to think about how the historic events that took place will be understood in years to come. To do so, we asked young scientists this question: What new word or phrase would you add to the dictionary to help s
Autor:
Alejandro J, Cagnoni, María Laura, Giribaldi, Ada G, Blidner, Anabela M, Cutine, Sabrina G, Gatto, Rosa M, Morales, Mariana, Salatino, Martín C, Abba, Diego O, Croci, Karina V, Mariño, Gabriel A, Rabinovich
Publikováno v:
Proc Natl Acad Sci U S A
Colorectal cancer (CRC) represents the third most common malignancy and the second leading cause of cancer-related deaths worldwide. Although immunotherapy has taken center stage in mainstream oncology, it has shown limited clinical efficacy in CRC,
Autor:
Ada G. Blidner, Rosa M. Morales, Sabrina G. Gatto, Anabela M. Cutine, Martín Carlos Abba, Karina Mariño, Gabriel A. Rabinovich, Alejandro J. Cagnoni, María Laura Giribaldi, Diego O. Croci, Mariana Salatino
Publikováno v:
SEDICI (UNLP)
Universidad Nacional de La Plata
instacron:UNLP
CONICET Digital (CONICET)
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
Universidad Nacional de La Plata
instacron:UNLP
CONICET Digital (CONICET)
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
Colorectal cancer (CRC) represents the third most common malignancy and the second leading cause of cancer-related deaths worldwide. Although immunotherapy has taken center stage in mainstream oncology, it has shown limited clinical efficacy in CRC,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf81a4ced10af6c8088f0d4a539ec1d4
http://sedici.unlp.edu.ar/handle/10915/146467
http://sedici.unlp.edu.ar/handle/10915/146467
Publikováno v:
Digital.CSIC. Repositorio Institucional del CSIC
instname
instname
Galectins are an endogenous family of β-galactoside-binding proteins that play complex and multifaceted roles at various stages of cancer progression, including modulation of tumor cell proliferation, signaling, adhesion, migration, invasion, epithe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9093e46776fc7a092989de295467beda
http://hdl.handle.net/10261/223728
http://hdl.handle.net/10261/223728